Telix Pharmaceuticals Investigation: Faruqi & Faruqi Encourages Investors to Contact Josh Wilson
ByAinvest
Friday, Nov 14, 2025 10:37 am ET1min read
TLX--
Faruqi & Faruqi, a national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited and reminds investors of the January 9, 2026 deadline to seek lead plaintiff in a federal securities class action. Investors who purchased or acquired Telix securities between February 21, 2025 and August 28, 2025, can contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their options.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet